icon star paper   Hepatitis C Articles (HCV)  
Back grey_arrow_rt.gif
 
 
New Pegasys Study for HCV+ Untreated Patients with Genotype 1, High Weight & High Viral Load
 
 
  "Pegasys in Combination with Copegus in Previously Untreated Patients with Chronic Hepatitis C Genotype 1 of High Viral Count and Body Weight > 85 kg (187 lbs)"
 
Source: www.clinicaltrials.gov
This study is currently recruiting patients.
Sponsored by Hoffmann-La Roche
 
Purpose of The Study
 
The objective of this study is to evaluate the effects of higher doses of Pegasys and Copegus in patients infected with Hepatitis C, whose body weight is greater than 85 kg (187 lbs) and who have a high viral count.
 
CONDITION: Chronic Hepatitis C
TREATMENT DRUGS: Pegylated Interferon alfa-2a in combination with Ribavirin
Phase IV Study
 
Official Title: Evaluation of the effect of Pegasys doses of 180 ug or 270 ug in combo w/ Copegus doses of 1200 mg or 1600 mg in previously untreatedpatients w/ Chronic Hepatitis C Genotype 1 of high viral count and body wt greater than 85 kg (187 lbs)
 
Eligibility
 
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both
 
Criteria
 
Inclusion Criteria:
 
--Age greater than or equal to 18 years
--Infected with Hepatitis C virus Genotype 1
--High Viral Count (HCV RNA count greater than 800,000 IU/mL)
--Body Weight greater than 85 kg (187 lbs)
 
Exclusion Criteria:
 
--Pregnant, breast-feeding or male partners of those who are pregnant
--Infection with Hepatitis C virus Genotype 2, 3, 4, 5, 6 or undetermined
--Previously treated with interferon, pegylated interferon, ribavirin, viramidine, levovirin or amantadine at any previous time or any other systemic antiviral therapy or investigational drug less than or equal to 3 months prior to first dose of study drug. Exception: Patients with a limited (less than or equal to 7 day) course of acyclovir or valacyclovir for herpes more than 1 month prior to first dose of study drug are not excluded.
 
Study Locations and Contact Information
 
Please reference Study ID Number: PDO-NV17318 973-235-5000 (Roche tel#)or 800-526-6367 (FOR US ONLY)
 
California
 
San Diego, California, 92120, United States; Recruiting
(619) 563-4040
 
Long Beach, California, 90822, United States; Recruiting
(562) 826-5933
 
La Jolla, California, 92037, United States; Recruiting
(858) 554-8097
 
Downey, California, 90242, United States; Completed

 
Connecticut
 
Farmington, Connecticut, 06030, United States; Recruiting
(860) 679-8156
(860) 679-3749
 
Florida
 
Gainesville, Florida, 32610-0214, United States; Recruiting
(352) 392-7956
(352) 392-5454
 
Jacksonville, Florida, 32207, United States; Recruiting
(904) 680-0871
 
Wellington, Florida, 33414, United States; Not yet recruiting
 
Bradenton, Florida, 34205, United States; Recruiting
(941) 746-2711
 
Hawaii
 
Honolulu, Hawaii, 96817, United States; Recruiting
(808) 547-6541
 
Illinois
 
Chicago, Illinois, 60612, United States; Recruiting
(312) 563-3903
 
Indiana
 
Indianapolis, Indiana, 46214-2985, United States; Completed
 
Iowa Iowa City, Iowa, 52242, United States; Recruiting
(319) 356-1660
 
Massachusetts
 
Boston, Massachusetts, 02111, United States; Recruiting
(617) 636-4532
 
Boston, Massachusetts, 02114, United States; Terminated
 
Minnesota
 
Plymouth, Minnesota, 55446, United States; Terminated
 
Missouri
 
St. Louis, Missouri, 63104, United States; Recruiting
 
New Jersey
 
Princeton, New Jersey, 08540-6233, United States; Completed
 
New York
 
Manhasset, New York, 11030, United States; Not yet recruiting
(516) 562-4281
 
North Carolina
 
Chapel Hill, North Carolina, 27599-7080, United States; Recruiting
(919) 966-6732
 
Charlotte, North Carolina, 28203, United States; Recruiting
 
Ohio
 
Cincinnati, Ohio, 45267, United States; Recruiting
(513) 584-5245
 
Pennsylvania
 
Philadelphia, Pennsylvania, 19104, United States; Not yet recruiting
 
Pittsburgh, Pennsylvania, 15213, United States; Recruiting
(412) 647-1462
(412) 647-1170
 
Texas
 
Houston, Texas, 77030, United States; Not yet recruiting
 
Utah
 
Salt Lake City, Utah, 84121, United States; Recruiting
(801) 944-3165
 
Virginia Richmond, Virginia, 23249, United States; Recruiting
(804) 675-5021
 
Charlottesville, Virginia, 22906-0013, United States; Not yet recruiting
(434) 924-2626
 
Canada, Ontario
 
Toronto, Ontario, M5G 1L7, Canada; Terminated
 
Puerto Rico
 
Santurce, 00909, Puerto Rico; Recruiting
(787) 722-1248
 
More Information
 
Study ID Numbers NV17318
Record last reviewed May 2004
NLM Identifier NCT00077649
ClinicalTrials.gov processed this record on 2004-06-04
 
 
 
 
  icon paper stack View Older Articles   Back to Top   www.natap.org